Parecer de pré-exame
#6.23
04/07/2026
RPI 2883
Application data
Number
112020013915Type
Filing
Publication
PCT
US2019012720 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 04/07/2026. We update with every new RPI gazette, published weekly.
Applicants
G1 THERAPEUTICS, INC.
US
Inventors
A. B. (pessoa física)
US
J. S. (pessoa física)
US
IPC Classification
Priority claims
US
62/614,952 · 01/08/2018
US
62/679,575 · 06/01/2018
US
62/788,017 · 01/03/2019
Abstract
Um regime de dosagem oral humana de G1T38 que fornece uma razão (AUC média (0-24),ss (h*ng/mL)) / (dose (mg)) inferior a 5 e/ou uma razão (AUC média (0-24),ss (h*ng/mL)) / (contagem absoluta de neutrófilos (células/mm3)) no dia 22 de término não superior a 1,25.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
04/07/2026
RPI 2883
#15.35
12/07/2021
RPI 2657
#1.3
12/01/2020
RPI 2604
#1.1
10/20/2020
RPI 2598
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.